Sareum Share Price (SAR)
SAR Share
SAR Share
SAR Share
SAR Share
SAR
SAR Share
SAR Level 2
SAR Live
SAR Broker
SAR Directors
SAR Financial
SAR
SAR Short
SAR
Last checked at -
| Sareum Share Price | |
|---|---|
| Price | 0.31 |
| Bid | 0.30 |
| Ask | 0.32 |
| Change | 0.00 (0.00%) |
| Volume | 1,472,909 |
| Open | 0.31 |
| High | 0.31 |
| Low | 0.31 |
| Close | 0.31 |
| Currency | GBX |
| Currency | GBX |
|---|---|
| Issue Country | GB |
| Shares in Issue | 3,071m |
| Market Capitalisation | £10m |
| Market Size | 300,000 |
| 52 Week High | 0.875 |
| 52 Week High Date | 22-Mar-2019 |
| 52 Week Low | 0.265 |
| 52 Week Low Date | 12-Aug-2019 |
| # Trades | 0 |
|---|---|
| Vol. Sold | 17,785 |
| Sold Value | £55.13 |
| Vol. Bought | 1,455,124 |
| Bought Value | £4,511 |
| PE Ratio | -6.20 |
| Earnings | -0.05 |
| Dividend | 0.00 |
| Yield | 0.00% |
| Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
|---|---|---|---|---|---|---|---|---|
| 20-Sep-19 | 15:18:37 | 0.319 | 100,000 | Buy* | 0.30 | 0.32 | 319.00 | O Ordinary |
| 20-Sep-19 | 15:14:20 | 0.308 | 6,427 | Sell* | 0.30 | 0.32 | 19.80 | O Ordinary |
| 20-Sep-19 | 14:52:23 | 0.319 | 76,504 | Buy* | 0.30 | 0.32 | 244.05 | O Ordinary |
| 20-Sep-19 | 13:26:11 | 0.319 | 78,369 | Buy* | 0.30 | 0.32 | 250.00 | O Ordinary |
| 20-Sep-19 | 10:18:43 | 0.306 | 11,358 | Sell* | 0.30 | 0.32 | 34.76 | O Ordinary |
| 20-Sep-19 | 10:12:56 | 0.319 | 133,150 | Buy* | 0.30 | 0.32 | 424.75 | O Ordinary |
| 20-Sep-19 | 09:35:58 | 0.318 | 153,303 | Buy* | 0.30 | 0.32 | 487.50 | O Ordinary |
| 20-Sep-19 | 09:15:28 | 0.3166 | 319,805 | Buy* | 0.30 | 0.32 | 1,013 | O Ordinary |
| 20-Sep-19 | 08:50:53 | 0.3166 | 15,162 | Buy* | 0.30 | 0.32 | 48.00 | O Ordinary |
| 20-Sep-19 | 08:38:57 | 0.3166 | 170,000 | Buy* | 0.30 | 0.32 | 538.22 | O Ordinary |
| Trade Date | Action | Notifier | Price | Currency | Amount | Holding |
|---|---|---|---|---|---|---|
| 08-Mar-17 | Buy | Stephen Parker held the position of Non-Executive Chairman at the time of this trade. Stephen Parker | 0.95 | GBX | 674,272 | 674,272 |
| 08-Mar-17 | Buy | Stephen Parker held the position of Non-Executive Chairman at the time of this trade. Stephen Parker | 0.95 | GBX | 461,949 | 674,272 |
| 07-Mar-11 | Sell | Timothy J Mitchell held the position of CEO at the time of this trade. Timothy J Mitchell | 2.45 | GBX | 250,000 | 42,280,471 |
| 07-Mar-11 | Sell | Timothy J Mitchell held the position of CEO at the time of this trade. Timothy J Mitchell | 2.45 | GBX | 250,000 | 0 |
| 30-Jun-09 | Notification of Holding | Dr Paul B Harper held the position of Non-Executive Chairman at the time of this trade. Dr Paul B Harper | 0.00 | 0 | 0 |
Sareum’s small molecule drug discovery expertise builds value by developing drug candidates, focused on cancer and autoimmune disease, for licencing to pharmaceutical and biotechnology companies.
Last checked at